Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
- Lyfgenia
Descriptions
Lovotibeglogene autotemcel injection is a one-time gene therapy used to treat sickle cell disease (red blood cell disease) in patients who have a history of vaso-occlusive events.
Sickle cell disease is a genetic, inherited, lifelong disease caused by an alteration in one of the genes in the red blood cell, the beta-globin gene that causes the normal disc-shaped red cells to take the shape of a sickle, causing anemia and vaso-occlusive events, like a pain crisis.
This medicine is to be given only by or under the immediate supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.